Grace Therapeutics GRCE
NASDAQ GRCE
$1.75 -0.06 (-3.31%)
At close: Nov 16, 2026 · 4:00 PM EST

Grace Therapeutics (GRCE) Gross Profit (2012 - 2021)

Updated

Grace Therapeutics (GRCE) posted Gross Profit of $75,000 for fiscal Q4 2021 (quarter ended Mar 31, 2021), up 66.7% from the prior quarter.

Analysis

Grace Therapeutics (GRCE) Gross Profit (2012 - 2021) Analysis & Trends

For FY2021 (ended Mar 31, 2021), Grace Therapeutics' Gross Profit came in at $120,000.

  • The fiscal Q4 2021 figure stands as the highest quarterly Gross Profit since fiscal Q4 2014.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Eli Lilly 1,276.89 Bn 1,250.50 Bn 20.46 Bn
2 Johnson & Johnson 681.31 Bn 601.18 Bn 17.30 Bn
3 AbbVie 520.63 Bn 488.64 Bn 13.12 Bn
4 Merck 357.22 Bn 320.16 Bn 13.19 Bn
5 Novartis Ag 310.90 Bn 284.14 Bn -
6 Astrazeneca 285.12 Bn 258.77 Bn 13.26 Bn
7 Amgen 250.23 Bn 201.89 Bn 7.58 Bn
8 Gilead Sciences 207.56 Bn 182.67 Bn 6.73 Bn
9 Pfizer 164.42 Bn 111.77 Bn 12.56 Bn
10 Grace Therapeutics 35.10 Mn -35.61 Mn -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2021 75,000.00
Dec 31, 2020 45,000.00
Nov 30, 2016 1,258.00
Aug 31, 2016 3,651.00
May 31, 2016 2,888.00
Feb 29, 2016 -53,609.00
Nov 30, 2015 2,683.00
Aug 31, 2015 4,665.00
May 31, 2015 2,499.00
Feb 28, 2015 -3,153.00
Nov 30, 2014 5,607.00
Aug 31, 2014 3,028.00
May 31, 2014 30,042.00
Feb 28, 2014 77,468.00
Nov 30, 2013 12,224.00
Aug 31, 2013 114,844.00
May 31, 2013 4,486.00
Feb 28, 2013 11,704.00
Nov 30, 2012 183,448.00
Aug 31, 2012 113,575.00
API Access

Grace Therapeutics Gross Profit API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=gross-profit&ticker=GRCE&period=max&api_key=YOUR_API_KEY